Emergency Remedies for Severe Hypoglycemia

Severe hypoglycemia is a life-threatening medical emergency that demands immediate recognition and swift intervention. When blood glucose levels drop dangerously low, the brain and other vital organs are deprived of their primary energy source, potentially leading to seizures, loss of consciousness, permanent neurological damage, or even death. Understanding how to identify and respond to severe hypoglycemia can mean the difference between a successful recovery and a tragic outcome. This comprehensive guide provides essential information about emergency remedies, prevention strategies, and follow-up care for severe hypoglycemic episodes.

Understanding Severe Hypoglycemia: Definition and Severity Levels

Hypoglycemia is defined as a blood glucose level at or below 70 mg/dL, but the condition exists on a spectrum of severity. Hypoglycemia has three levels: Level 1 is blood glucose less than 70 mg/dL but at or over 54 mg/dL, Level 2 is blood glucose less than 54 mg/dL, and Level 3 is when blood glucose has affected the ability to think or control the body requiring help to treat it. The most critical classification is severe hypoglycemia, which represents a medical emergency.

Severe hypoglycemia is defined as an event with severe cognitive impairment (including coma and convulsions) requiring assistance by another person to administer carbohydrates, glucagon, or intravenous dextrose. This definition emphasizes that the person experiencing severe hypoglycemia cannot treat themselves and requires external intervention. Severe hypoglycemia is also defined as blood glucose less than 54 mg/dL or altered mental and physical functioning that requires assistance from another person for recovery.

Severe hypoglycemia is a medical emergency, and it is important for patients with diabetes and their close contacts—including pharmacists and other healthcare providers—to recognize symptoms of hypoglycemia and proceed with proper treatment. The urgency cannot be overstated, as the brain uses glucose as its primary energy source, neuronal damage may occur if treatment of hypoglycemia is delayed.

Recognizing the Signs and Symptoms of Severe Hypoglycemia

Early recognition of severe hypoglycemia is critical for timely intervention. The symptoms can progress rapidly from mild warning signs to life-threatening complications. Understanding both the early warning signs and the severe manifestations helps caregivers and family members respond appropriately.

Early Warning Signs

Before hypoglycemia becomes severe, individuals may experience various warning symptoms that signal dropping blood sugar levels. These early signs include shakiness, dizziness or lightheadedness, sweating, confusion, nervousness or irritability, sudden changes in behavior or mood, headache, and numbness or tingling around the mouth. Recognizing these symptoms early allows for intervention with oral glucose before the situation becomes critical.

Symptoms of hypoglycemia can differ from person to person, and it is important that individuals learn their own signs of low blood sugar so that they can treat it quickly. This personalized awareness is particularly important for people with diabetes who use insulin or certain oral medications that increase hypoglycemia risk.

Severe Hypoglycemia Symptoms

When hypoglycemia progresses to a severe state, the symptoms become dramatically more serious and require immediate emergency intervention. Severe symptoms include:

Severe confusion and disorientation – The person may not recognize familiar people or places
Loss of consciousness or unresponsiveness – The individual cannot be awakened or does not respond to verbal or physical stimuli
Seizures or convulsions – Involuntary muscle contractions that can be violent
Inability to swallow – Making oral treatment impossible and dangerous due to choking risk
Altered mental status – Extreme drowsiness, inability to speak coherently, or bizarre behavior
Coma – Complete loss of consciousness with no response to stimuli

Hypoglycemic coma is a subgroup of severe hypoglycemia defined as an event associated with a seizure or loss of consciousness. This represents the most critical presentation requiring immediate emergency medical intervention.

Hypoglycemia Unawareness

A particularly dangerous condition called hypoglycemia unawareness can develop in some individuals with diabetes. Impaired hypoglycemia awareness can occur in children with diabetes and when present, is associated with a significantly increased risk of severe hypoglycemia. This condition means the person does not experience the typical early warning symptoms of dropping blood sugar, allowing glucose levels to fall to dangerous levels before any symptoms appear.

The determination of hypoglycemia awareness should be a component of routine clinical review, and impaired awareness may be corrected by avoidance of hypoglycemia. People with hypoglycemia unawareness require extra vigilance, more frequent blood glucose monitoring, and should always have glucagon readily available.

Immediate Emergency Response: Critical Steps to Take

When someone exhibits signs of severe hypoglycemia, every second counts. The response must be swift, organized, and follow established emergency protocols. Here is the comprehensive step-by-step approach to managing a severe hypoglycemic emergency.

Step 1: Call Emergency Services Immediately

The first action when encountering someone with suspected severe hypoglycemia is to call for professional medical help. Dial your local emergency number (911 in the United States) immediately. In view of the multiple causes of a sudden episode of hypoglycemia in a patient with previously well-controlled diabetes, it is prudent to advise transport and emergency department evaluation.

Do not delay calling emergency services while attempting other interventions. Professional medical personnel can provide advanced care, including intravenous glucose administration if needed, and can address any complications that may arise. Even if the person responds to initial treatment, emergency medical evaluation is essential to determine the underlying cause and prevent recurrence.

Step 2: Administer Glucagon If Available

Severe hypoglycemia requires urgent treatment, and if the child is unconscious or unable to swallow, hypoglycemia can be safely reversed by administration of glucagon, a potent and effective agent that can be administered intravenously, intranasally, intramuscularly or subcutaneously. Glucagon is the primary emergency treatment for severe hypoglycemia when the person cannot safely consume oral carbohydrates.

Glucagon, a counterregulatory pancreatic hormone, causes the breakdown and release of glycogen from the liver to increase blood glucose concentrations. Glucagon, preferably ready-to-use, should be used to treat severe hypoglycemia as it quickly raises blood glucose levels by causing the liver to release the glucose it stores into the bloodstream.

Types of Glucagon Products Available

Several formulations of glucagon are now available, making emergency administration easier than ever before:

Traditional Injectable Glucagon Kits – Commercially available glucagon rescue kits include GlucaGen HypoKit 1 mg and Glucagon Emergency Rescue Kit. These require reconstitution before use, mixing powder with liquid diluent.
Nasal Glucagon – A single 3 mg dose of nasal glucagon for children greater than 4 years is available. Powder glucagon uses a device similar in size to a typical nasal spray to drive powdered glucagon into the nose where it’s absorbed into the bloodstream in a fast, one-step process, and because it’s needle-free, it may be less scary for caregivers and easier to deliver correctly.
Pre-mixed Injectable Glucagon – The pre-mixed device works similarly to EpiPens and other injectable pen medications, containing a stable form of glucagon that’s ready to immediately be injected without mixing.
Dasiglucagon – Dasiglucagon, a stable glucagon analog, available as 0.6 mg ready-to-use pen subcutaneously for children 6 years and older.

Proper Glucagon Dosing

Correct dosing is essential for effective treatment. The recommended glucagon dose is weight based: 1 mg for adults and children greater than 25 kg and 0.5 mg for children less than 25 kg. The entire 1 mg is administered subcutaneously or intramuscularly in adults and children weighing greater than 20 kg; in children less than 20 kg, 0.5 mg is administered.

How to Administer Traditional Injectable Glucagon

For traditional glucagon emergency kits that require reconstitution, follow these steps carefully:

Remove the seal from the vial of powder and the needle cover from the syringe, then insert the needle into the vial and push the plunger to empty the saline into the powder
Gently roll or swirl the vial to dissolve the powder into the liquid until it is clear
Draw the solution back into the syringe
Inject into the outer mid-thigh or arm muscle of the person with severe hypoglycemia
Turn the person on his or her side in case of vomiting, a common side effect

You can inject glucagon into the top of the thigh (upper leg), outer buttock area, or upper outer arm. Put the needle into the skin in one quick motion at a 90-degree angle (straight up and down).

Expected Response Time and Follow-up Dosing

Patients normally respond within 15 minutes to glucagon administration. An unconscious person with hypoglycemia will usually wake up within 15 minutes, and if the person does not awaken within 15 minutes after an injection, inject one more dose.

Glucagon is not effective for much longer than 1½ hours and is used only until the patient is able to swallow. This temporary effect underscores the importance of follow-up treatment with oral carbohydrates once the person regains consciousness and can safely swallow.

Step 3: Position the Person Safely

Proper positioning is crucial to prevent complications during and after glucagon administration. After the injection, turn the patient onto their side to prevent choking if they vomit. Roll the person onto their side as glucagon sometimes makes people vomit, and turning them onto their side will help keep them from choking.

The recovery position (lying on the side) is essential because:

It keeps the airway open and clear
It allows any vomit to drain from the mouth rather than being aspirated into the lungs
It prevents the tongue from blocking the airway
It provides a stable position while waiting for emergency services

Nasal glucagon can be given to an unconscious person, and if given to an unconscious person, turn them on their side to avoid possibly choking on vomit. This positioning applies regardless of which glucagon formulation is used.

Step 4: Do Not Give Food or Drink to an Unconscious Person

One of the most critical safety rules in managing severe hypoglycemia is never attempting to give anything by mouth to an unconscious or semi-conscious person. Patients with decreased levels of consciousness cannot safely consume oral carbohydrates to raise their blood sugar levels due to the risk of aspiration.

Attempting to force food, liquids, or glucose tablets into the mouth of someone who cannot swallow properly can result in:

Choking and airway obstruction
Aspiration of food or liquid into the lungs, leading to aspiration pneumonia
Worsening of the emergency situation
Delayed proper treatment

Wait until the person is fully conscious, alert, and able to swallow safely before offering any oral carbohydrates. Once they can swallow, immediate feeding with fast-acting sugars followed by complex carbohydrates is essential to prevent recurrence.

Step 5: Monitor and Provide Post-Recovery Nutrition

Once the person regains consciousness and can safely swallow, immediate nutrition is critical. Feed the person a fast-acting source of sugar (e.g., regular soft drink or fruit juice) and then a long-acting source of sugar (e.g., crackers, cheese or a meat sandwich) as soon as they awaken and are able to swallow.

Fruit juice, corn syrup, honey, and sugar cubes or table sugar (dissolved in water) all work quickly, and if a snack or meal is not scheduled for an hour or more, the patient should also eat some crackers and cheese or half a sandwich, or drink a glass of milk to prevent hypoglycemia from occurring again before the next meal or snack.

The patient or caregiver should continue to monitor the patient’s blood sugar, and for about 3 to 4 hours after the patient regains consciousness, the blood sugar should be checked every hour. This frequent monitoring helps detect any recurrence early and ensures blood glucose levels stabilize.

Intravenous Dextrose: Hospital Treatment for Severe Hypoglycemia

When severe hypoglycemia occurs in a hospital setting or when emergency medical services arrive, intravenous (IV) dextrose becomes the preferred treatment method. IV glucose must be administered as soon as possible to any patient failing to respond to glucagon.

IV Dextrose Administration Protocol

Concentrated IV dextrose 50% (D50W) is most appropriate for severe hypoglycemia, providing 25 g of dextrose in a standard 50-mL bag, and it is recommended to administer 10 to 25 g over 1 to 3 minutes. Emergency medical services care generally consists of drawing serum glucose or using Accu-Chek prior to administering dextrose 50% in water (D50) in the field.

According to 2024 Italian guidelines on the prevention and treatment of hypoglycemia in children and adolescents with diabetes, severe hypoglycemia in such patients, when managed in a hospital setting, should be treated immediately with intravenous glucose (recommended dose 0.2 g/kg) to limit the patient’s exposure to hypoglycemia. The guidelines caution that clinicians should avoid highly concentrated glucose solutions (50%) or infusion rates above 5 mg/kg/min, owing to the risk of excessive rate of osmotic change and, consequently, hyperosmolar cerebral injury.

Advantages of IV Dextrose

Intravenous dextrose offers several advantages in the hospital or emergency medical services setting:

Rapid action – Glucose enters the bloodstream immediately, raising blood sugar levels within minutes
Precise dosing – Healthcare providers can administer exact amounts and adjust as needed
Continuous administration – IV infusions can be maintained to prevent recurrence
Monitoring capability – Blood glucose can be checked frequently and treatment adjusted accordingly
Effective when glucagon fails – Works even when liver glycogen stores are depleted

IV glucose increases the risk of severe tissue necrosis in the event of medication extravasation, which is why proper IV placement and monitoring are essential. Glucagon provides a reliable alternative for raising glucose levels and alleviating severe hypoglycemia, allowing time for more definitive correction when IV access is unavailable or has failed.

Special Considerations and Contraindications

While glucagon is generally safe and effective for treating severe hypoglycemia, certain medical conditions and situations require special consideration or alternative treatments.

When Glucagon May Not Be Effective

Glucagon is effective in treating hypoglycemia only if sufficient liver glycogen is present, and because glucagon is of little or no help in states of starvation, adrenal insufficiency, or chronic hypoglycemia, hypoglycemia in these conditions should be treated with glucose. The hormone works by stimulating the liver to release stored glucose, so if those stores are depleted, glucagon will not be effective.

Conditions where glucagon may be less effective or ineffective include:

Prolonged fasting or starvation
Chronic malnutrition
Adrenal insufficiency
Chronic hypoglycemia
Severe liver disease with depleted glycogen stores
Alcohol intoxication (which depletes liver glycogen)

Contraindications for Glucagon Use

If you have pheochromocytoma (tumor on a small gland near the kidneys), insulinoma or glucagonoma (types of pancreatic tumors), your doctor may tell you not to use glucagon injection. These conditions represent absolute or relative contraindications because:

Pheochromocytoma – The positive inotropic effects of glucagon can trigger severe hypertension in patients with pheochromocytoma
Insulinoma – In patients with insulinoma, IV glucagon may directly or indirectly (through an initial rise in blood glucose) stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia
Glucagonoma – Glucagon administration could worsen symptoms in patients with glucagon-secreting tumors

Common Side Effects of Glucagon

Nausea is the most commonly reported adverse effect of glucagon administration, with an incidence reaching up to 35% in some studies. Other side effects may include:

Vomiting (which is why positioning on the side is critical)
Hypertension may occur for up to 2 hours following administration, particularly in gastrointestinal cases, due to glucagon’s inotropic effects
Temporary increase in heart rate and blood pressure
Severe anaphylactic reactions, including hypotension, rash, and vomiting, have been reported due to its protein structure
Rebound hypoglycemia (particularly in patients with insulinoma)

The likelihood of adverse reactions increases with higher doses and the IV route of administration. Most side effects are temporary and resolve quickly, but awareness of these potential reactions helps caregivers respond appropriately.

Who Is at Risk for Severe Hypoglycemia?

Understanding risk factors for severe hypoglycemia helps identify individuals who need glucagon readily available and require extra vigilance in diabetes management.

High-Risk Populations

In a cohort study of 201,705 adults with diabetes, patients who were at greatest risk for an episode of hypoglycemia requiring an emergency department visit or hospitalization were those with type 1 diabetes mellitus, multiple comorbidities, prior severe hypoglycemia, or sulfonylurea or insulin use.

Specific high-risk groups include:

People with Type 1 Diabetes – Particularly those on intensive insulin therapy attempting tight glycemic control
Insulin Users – Anyone using insulin, especially long-acting or rapid-acting formulations
Sulfonylurea Users – These medications stimulate insulin release and can cause prolonged hypoglycemia
History of Severe Hypoglycemia – Previous episodes significantly increase the risk of future events
Hypoglycemia Unawareness – Inability to recognize early warning symptoms
Elderly Patients – Age-related changes in metabolism and kidney function increase risk
Patients with Kidney Disease – Impaired kidney function affects insulin clearance
Patients with Liver Disease – Reduced ability to produce and store glucose
Young Children – May not recognize or communicate symptoms effectively
People Who Exercise Intensely – Physical activity increases glucose utilization
Those Who Consume Alcohol – Alcohol impairs the liver’s ability to produce glucose

Certain diabetes medications carry higher hypoglycemia risk than others. Insulin and sulfonylureas are the primary culprits, while newer medications like metformin, SGLT2 inhibitors, and GLP-1 receptor agonists have much lower hypoglycemia risk when used alone.

All patients at high risk for hypoglycemia should have glucagon available, and prior to prescribing a glucagon product, a discussion should take place to determine the preferred glucagon formulation based on device and administration to ensure timely treatment of a hypoglycemic event.

Preventing Severe Hypoglycemia: Proactive Strategies

While knowing how to treat severe hypoglycemia is essential, prevention is always preferable. Multiple strategies can significantly reduce the risk of severe hypoglycemic episodes.

Blood Glucose Monitoring and Technology

Hypoglycemia can be detected using self-monitoring of blood glucose or continuous glucose monitoring, and newer factory-calibrated CGM devices are approved to make diabetes-related decisions. A decline in the frequency and duration of hypoglycemic episodes can be achieved using such technologies as continuous glucose monitoring (CGM), predictive low glucose management (PLGM), and automated insulin delivery (AID) systems.

Modern diabetes technology offers unprecedented protection against severe hypoglycemia:

Continuous Glucose Monitors (CGM) – Provide real-time glucose readings and trend arrows showing direction and rate of change
Low Glucose Alerts – Warn users before glucose drops to dangerous levels
Predictive Alerts – Notify users when glucose is predicted to go low within 20-30 minutes
Insulin Pump Suspend Features – Automatically stop insulin delivery when glucose is low or predicted to go low
Automated Insulin Delivery Systems – Adjust insulin delivery continuously based on CGM readings

Glycemic Target Adjustment

Glucose value less than 3.9 mmol/L (70 mg/dL) is used as the clinical alert or threshold value for initiating treatment for hypoglycemia because of the potential for glucose to fall further and avoid consequences of glucose levels below 3 mmol/L. For individuals at high risk of severe hypoglycemia, healthcare providers may recommend less stringent glycemic targets to reduce risk while still maintaining reasonable diabetes control.

Individualized glycemic targets should consider:

History of severe hypoglycemia
Hypoglycemia unawareness
Life expectancy and comorbidities
Patient preferences and quality of life
Ability to recognize and treat hypoglycemia
Support system and living situation

Education and Preparedness

ISPAD guidelines recommend that glucagon should be readily accessible to all parents and caregivers, especially when there is a high risk of severe hypoglycemia, and the guidelines note that education on how glucagon should be administered is essential.

It is important that all patients have a household member who knows the symptoms of low blood sugar and how to administer glucagon. Show your family members and others where you keep this kit and how to use it as they need to know how to use it before you need it, and it is important that they practice because a person who has never given a shot probably will not be able to do it in an emergency.

Comprehensive education should include:

Recognition of hypoglycemia symptoms at all severity levels
Proper use of blood glucose meters and CGM systems
Hands-on practice with glucagon administration (using training kits)
Understanding of when to call emergency services
Knowledge of factors that increase hypoglycemia risk
Meal timing and carbohydrate counting
Exercise precautions and glucose management during physical activity
Alcohol consumption guidelines and risks

Training on glucagon administration requires “hands on” practice and follow-up assessment of skills. Studies have shown that without proper hands-on training, many caregivers struggle to correctly prepare and administer glucagon during an emergency.

Lifestyle Modifications

Several lifestyle factors significantly impact hypoglycemia risk:

Consistent Meal Timing – General hypoglycemia education should also emphasize the importance of ensuring forward planning of meal timing and timing of insulin dosing if the individual is going to be driving, traveling or partaking in recreational activity
Regular Carbohydrate Intake – Frequent meals/snacks with complex carbohydrates are preferred, especially at night
Alcohol Awareness – Limit alcohol consumption and never drink on an empty stomach; always consume food with alcohol
Exercise Planning – Check glucose before, during, and after exercise; adjust insulin or consume extra carbohydrates as needed
Sick Day Management – Have a plan for managing diabetes during illness when eating patterns may be disrupted

Medication Management

Working with healthcare providers to optimize medication regimens can significantly reduce hypoglycemia risk:

Consider switching to insulin analogs with lower hypoglycemia risk
Evaluate whether sulfonylureas can be replaced with medications that don’t cause hypoglycemia
Adjust insulin doses based on CGM data and patterns
Use insulin pump features like temporary basal rates for exercise or illness
Review all medications for potential interactions that could affect glucose levels

Follow-Up Care After a Severe Hypoglycemic Episode

Recovery from severe hypoglycemia doesn’t end when blood glucose returns to normal. Comprehensive follow-up care is essential to prevent future episodes and address any underlying issues.

Immediate Post-Episode Care

Immediately contact a doctor and get emergency medical treatment after administering glucagon, even if the person responds well. If nausea and vomiting prevent the patient from swallowing some form of sugar for an hour after glucagon is given, medical help should be obtained, and keep your doctor informed of any hypoglycemic episodes or use of glucagon even if the symptoms are successfully controlled and there seem to be no continuing problems.

Emergency department evaluation typically includes:

Comprehensive blood glucose monitoring
Assessment for complications from the hypoglycemic episode
Evaluation for injuries sustained during seizures or loss of consciousness
Investigation of the cause of the severe hypoglycemia
Adjustment of diabetes medications if needed
Observation period to ensure glucose stabilization

In a cross-sectional study of 291 adults presenting to the emergency department with hypoglycemia or altered mental status resolved by glucagon or glucose, routine laboratory testing is justified in patients presenting to the ED with hypoglycemia, because of the high rate of abnormal laboratory results. This testing helps identify contributing factors like kidney dysfunction, electrolyte imbalances, or infections.

Determining the Underlying Cause

Understanding why severe hypoglycemia occurred is critical for prevention. Common causes include:

Medication Errors – Taking too much insulin or diabetes medication, or taking medication at the wrong time
Missed or Delayed Meals – Not eating enough carbohydrates or skipping meals after taking insulin
Increased Physical Activity – Exercise without adjusting insulin or carbohydrate intake
Alcohol Consumption – Drinking alcohol, especially without food
Illness or Infection – Unrecognized infection causing hypoglycemia in patients with diabetes may result in recurrent hypoglycemic spells or progression of the infection
Kidney or Liver Disease – Impaired organ function affecting glucose metabolism
Hormonal Deficiencies – Adrenal insufficiency or other endocrine disorders
Drug Interactions – New medications that interact with diabetes drugs

Adjusting the Diabetes Management Plan

After a severe hypoglycemic episode, the diabetes management plan typically requires modification. Healthcare providers should:

Review and adjust insulin doses or other diabetes medications
Reassess glycemic targets and consider less stringent goals if appropriate
Evaluate the need for CGM if not already in use
Consider insulin pump therapy or automated insulin delivery systems
Increase frequency of blood glucose monitoring temporarily
Provide additional diabetes education focusing on hypoglycemia prevention
Ensure glucagon is prescribed and caregivers are trained in its use
Schedule more frequent follow-up appointments

Psychological Impact and Support

Severe hypoglycemia can have significant psychological effects on both patients and caregivers. Fear of recurrence may lead to:

Anxiety about future episodes
Intentionally running blood glucose levels higher to avoid hypoglycemia
Reduced quality of life
Fear of sleeping alone or being alone
Reluctance to exercise or engage in normal activities
Depression or post-traumatic stress

Addressing these psychological impacts through counseling, support groups, and reassurance is an important component of comprehensive diabetes care. Mental health support should be offered to both patients and family members affected by the traumatic experience.

Long-Term Monitoring and Prevention

At each follow-up appointment, a patient’s overall hypoglycemic risk should be assessed and appropriate counselling should be provided. Regular monitoring should include:

Review of blood glucose logs or CGM data for patterns
Assessment of hypoglycemia awareness status
Evaluation of medication adherence and technique
Discussion of any mild or moderate hypoglycemic episodes
Review of glucagon availability and expiration dates
Confirmation that caregivers remain trained and confident in emergency response
Assessment of lifestyle factors affecting glucose control

Following initial hypoglycemia treatment, blood glucose should be retested in 15 minutes, and if there is no response or an inadequate response, repeat hypoglycemia treatment, then retest glucose in another 15 minutes to confirm that target glucose has been reached. This 15-15 rule applies to all levels of hypoglycemia treatment and helps ensure adequate recovery.

Glucagon Accessibility and Preparedness

Having glucagon available when needed can be lifesaving, but many at-risk individuals do not have it readily accessible. Addressing barriers to glucagon access and ensuring proper preparedness is essential.

Who Should Have Glucagon Available

A glucagon kit for emergency treatment of hypoglycemia is recommended for any patient with a history of severe hypoglycemia or who is at risk for it. All patients at high risk for hypoglycemia should have glucagon available.

Specifically, glucagon should be prescribed for:

All individuals with type 1 diabetes
People with type 2 diabetes using insulin, especially multiple daily injections or pump therapy
Anyone with a history of severe hypoglycemia
Individuals with hypoglycemia unawareness
People living alone or spending significant time alone
Children and adolescents with diabetes
Elderly individuals with diabetes on insulin or sulfonylureas
Anyone with unpredictable eating patterns or activity levels

Where to Keep Glucagon

Family members, friends and caregivers should know where the glucagon is stored and how to administer this in the event of an emergency in the outpatient, community setting. Strategic placement of glucagon ensures it’s available when needed:

At Home – Keep in an easily accessible location known to all household members; consider keeping one in the bedroom and one in a common area
At School or Work – Provide glucagon to school nurses, teachers, or workplace first aid stations with proper training
During Travel – If you have low blood sugar often, keep glucagon injection with you at all times
In Vehicles – Keep a kit in the car for emergencies while traveling
At Caregivers’ Homes – Provide glucagon to grandparents, babysitters, or other regular caregivers

Check expiration dates regularly and replace glucagon before it expires. Most glucagon products have a shelf life of 18-24 months when stored properly at room temperature.

Training and Practice

Having glucagon available is only helpful if caregivers know how to use it correctly. Close contacts of the patient (e.g., family, friends, neighbors, caregivers) should be educated on the location and appropriate use of the glucagon kit should they find the person in a state of altered consciousness.

Effective training should include:

Demonstration by healthcare providers
Hands-on practice with training kits or expired glucagon
Written instructions kept with the glucagon kit
Video demonstrations available online
Regular refresher training (at least annually)
Practice scenarios to build confidence
Clear instructions on when to call 911

Many glucagon manufacturers provide training kits that allow practice without using actual medication. These training tools are invaluable for building confidence and competence in emergency glucagon administration.

Special Populations: Children, Elderly, and Pregnant Women

Certain populations require special considerations in the management and prevention of severe hypoglycemia.

Children and Adolescents

Children with type 1 diabetes should spend less than 4% of their time below 3.9 mmol/L (70 mg/dL) and less than 1% of their time below 3.0 mmol/L (54 mg/dL). Young children face unique challenges with hypoglycemia:

May not recognize or communicate symptoms effectively
Depend entirely on caregivers for treatment
Have unpredictable eating and activity patterns
Require weight-based glucagon dosing
Need glucagon available at school, daycare, and with all caregivers

The safety and effectiveness of glucagon injections have been established for treating severe hypoglycemia in pediatric patients with diabetes. Parents, teachers, coaches, and other caregivers must be thoroughly trained in recognizing and treating severe hypoglycemia in children.

Elderly Patients

Older adults with diabetes face increased hypoglycemia risk due to multiple factors:

Multiple comorbidities and medications
Reduced kidney and liver function affecting drug clearance
Cognitive impairment affecting diabetes self-management
Reduced hypoglycemia awareness
Living alone with limited support
Irregular eating patterns
Increased fall risk during hypoglycemic episodes

Less stringent glycemic targets are often appropriate for elderly patients to reduce hypoglycemia risk while maintaining quality of life. CGM technology can be particularly beneficial for older adults and their caregivers to monitor glucose levels remotely.

Pregnant Women

Pregnancy significantly affects glucose metabolism and hypoglycemia risk. Pregnant women with diabetes require:

More frequent blood glucose monitoring
Tighter glycemic control to protect fetal development
Increased awareness of hypoglycemia risk, especially in the first trimester
Glucagon readily available
Partner or family member trained in glucagon administration
Close coordination with maternal-fetal medicine specialists

Glucagon can be used safely during pregnancy when needed for severe hypoglycemia. The benefits of treating severe hypoglycemia far outweigh any theoretical risks to the fetus.

The Role of Healthcare Providers and Pharmacists

Pharmacists can help reduce a patient’s risk for hypoglycemia, as well as ensure the condition’s proper recognition and treatment, should it occur. Healthcare teams play a crucial role in preventing and managing severe hypoglycemia.

Comprehensive Risk Assessment

Healthcare providers should regularly assess hypoglycemia risk at every visit, considering:

Current medications and doses
History of hypoglycemic episodes
Hypoglycemia awareness status
Glycemic control and variability
Lifestyle factors and support system
Comorbidities affecting hypoglycemia risk
Patient’s ability to recognize and treat hypoglycemia

Patient Education and Empowerment

Comprehensive diabetes education should include:

Detailed instruction on hypoglycemia recognition and treatment
Hands-on training with glucose meters and CGM systems
Glucagon administration training for patients and caregivers
Carbohydrate counting and meal planning
Exercise management strategies
Sick day management protocols
When to seek emergency medical care

Medication Optimization

Healthcare providers should regularly review diabetes medications to minimize hypoglycemia risk while maintaining glycemic control. This includes:

Considering medications with lower hypoglycemia risk when appropriate
Adjusting insulin regimens based on CGM data and patterns
Evaluating the need for insulin pump therapy or automated insulin delivery
Reviewing all medications for potential interactions
Ensuring proper insulin injection technique

Ensuring Glucagon Access

Pharmacists and prescribers should work together to ensure glucagon access by:

Prescribing glucagon for all appropriate patients
Discussing different glucagon formulations and helping patients choose the most appropriate option
Addressing insurance coverage and cost barriers
Providing training on glucagon administration at the pharmacy
Reminding patients to check expiration dates and replace as needed
Ensuring patients have multiple glucagon kits in different locations

Emerging Treatments and Future Directions

The landscape of hypoglycemia treatment continues to evolve with new technologies and formulations designed to make emergency treatment easier and more effective.

Newer Glucagon Formulations

Recent years have seen the introduction of several new glucagon products that address the limitations of traditional reconstituted glucagon. These include ready-to-use formulations that eliminate the need for mixing, making emergency administration faster and easier for stressed caregivers.

The availability of nasal glucagon has been particularly transformative, as it requires no injection and can be administered quickly even by individuals uncomfortable with needles. Pre-filled auto-injector devices similar to epinephrine auto-injectors have also simplified the administration process.

Advanced Diabetes Technology

Continuous glucose monitoring systems with predictive low glucose alerts and automated insulin delivery systems that suspend or reduce insulin delivery before hypoglycemia occurs have dramatically reduced severe hypoglycemia rates in many patients. These technologies represent a paradigm shift from reactive treatment to proactive prevention.

Future developments may include:

More sophisticated algorithms for predicting and preventing hypoglycemia
Integration of multiple data sources (activity trackers, meal logging, etc.) to improve glucose predictions
Bi-hormonal artificial pancreas systems that deliver both insulin and glucagon
Implantable glucose sensors with longer wear times
Improved hypoglycemia detection algorithms

Research on Hypoglycemia Prevention

Ongoing research continues to explore ways to prevent severe hypoglycemia and restore hypoglycemia awareness in those who have lost it. Studies are investigating medications that might help restore counter-regulatory responses, behavioral interventions to improve hypoglycemia awareness, and optimal strategies for diabetes management in high-risk populations.

Living with Hypoglycemia Risk: Quality of Life Considerations

The constant awareness of hypoglycemia risk affects quality of life for people with diabetes and their families. Fear of severe hypoglycemia can be debilitating, leading to anxiety, sleep disturbances, and reluctance to engage in normal activities.

Strategies to maintain quality of life while managing hypoglycemia risk include:

Building Confidence – Comprehensive education and practice with emergency procedures builds confidence in managing hypoglycemia
Using Technology – CGM systems with alarms provide reassurance and early warning
Creating Support Networks – Connecting with others who understand the challenges through support groups or online communities
Maintaining Perspective – While vigilance is important, avoiding excessive anxiety that interferes with daily life
Seeking Professional Support – Working with mental health professionals when fear of hypoglycemia becomes overwhelming
Celebrating Successes – Recognizing improvements in glucose management and reductions in hypoglycemia frequency

Conclusion: Preparedness Saves Lives

Severe hypoglycemia is a serious medical emergency that requires immediate recognition and treatment. Understanding the symptoms, having glucagon readily available, ensuring caregivers are properly trained, and knowing when to call emergency services can be lifesaving. While severe hypoglycemia is frightening, it is treatable, and with proper preparation, most episodes can be successfully managed.

The key elements of effective severe hypoglycemia management include rapid recognition of symptoms, immediate administration of glucagon when the person cannot safely swallow, proper positioning to prevent aspiration, calling emergency services, and comprehensive follow-up care to prevent recurrence. Prevention through appropriate use of diabetes technology, individualized glycemic targets, comprehensive education, and lifestyle modifications can significantly reduce the risk of severe hypoglycemic episodes.

For individuals at risk of severe hypoglycemia, having glucagon available at all times and ensuring that family members, friends, and caregivers know how to use it is not optional—it is essential. The few minutes spent learning proper glucagon administration could save a life. Regular review of emergency procedures, checking glucagon expiration dates, and maintaining open communication with healthcare providers about hypoglycemia risk ensures optimal preparedness.

As diabetes management continues to evolve with new technologies and treatments, the goal remains clear: to help people with diabetes achieve good glycemic control while minimizing the risk of severe hypoglycemia. With proper education, preparation, and support, individuals with diabetes can live full, active lives while managing this serious but treatable complication.

For more information about diabetes management and hypoglycemia, visit the American Diabetes Association, consult with your healthcare provider, or contact diabetes education programs in your area. Remember, knowledge and preparation are your best defenses against severe hypoglycemia.

Table of Contents